Michael T Gillin
Overview
Explore the profile of Michael T Gillin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1009
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dawson L, Winter K, Knox J, Zhu A, Krishnan S, Guha C, et al.
JAMA Oncol
. 2024 Dec;
11(2):136-144.
PMID: 39699905
Importance: Most patients with locally advanced hepatocellular carcinoma (HCC) recur within the liver following systemic therapy. Objective: To determine whether stereotactic body radiation therapy (SBRT) improves outcomes in patients with...
2.
Monte Carlo Simulations of Neutron Ambient Dose Equivalent in a Novel Proton Therapy Facility Design
Titt U, Pera E, Gillin M
Int J Part Ther
. 2020 Jun;
6(4):29-37.
PMID: 32582817
Purpose: The neutron shielding properties of the concrete structures of a proposed proton therapy facility were evaluated with help of the Monte Carlo technique. The planned facility's design omits the...
3.
Wu R, Williamson T, Sahoo N, Nguyen T, Ikner S, Liu A, et al.
Phys Imaging Radiat Oncol
. 2020 Jun;
13:44-49.
PMID: 32551371
Background And Purpose: Computed tomography (CT) scanning is the basis for radiation treatment planning, but the 50-cm standard scanning field of view (sFOV) may be too small for imaging larger...
4.
Abrams R, Winter K, Safran H, Goodman K, Regine W, Berger A, et al.
Am J Clin Oncol
. 2020 Jan;
43(3):173-179.
PMID: 31985516
Purpose: NRG/RTOG 0848 was designed to determine whether adjuvant radiation with fluoropyrimidine sensitization improved survival following gemcitabine-based adjuvant chemotherapy for patients with resected pancreatic head adenocarcinoma. In step 1 of...
5.
Wu R, Liu A, Sio T, Blanchard P, Wages C, Amin M, et al.
Int J Part Ther
. 2019 Nov;
4(2):26-34.
PMID: 31773006
Purpose: The authors aimed to illustrate the potential dose differences to clinical target volumes (CTVs) and organs-at-risk (OARs) volumes after proton adaptive treatment planning was used. Patients And Methods: The...
6.
Jiang S, Wang J, Li H, Liao L, Li Y, Wang X, et al.
Int J Part Ther
. 2019 Nov;
3(1):37-50.
PMID: 31772974
Purpose: To determine whether a hybrid intensity-modulated proton therapy (IMPT) and passive scattered proton therapy (PSPT) technique, termed HimpsPT, could be adopted as an alternative delivery method for patients demanding...
7.
Wu R, Liu A, Wisdom P, Zhu X, Frank S, Fuller C, et al.
J Appl Clin Med Phys
. 2018 Dec;
20(1):145-153.
PMID: 30580471
The purpose of this study was to describe a new user-friendly, low-cost phantom that was developed to test the accuracy of rigid and deformable image registration (DIR) systems and to...
8.
Wang X, Li Y, Zhang X, Li H, Miyazaki K, Fujimoto R, et al.
Cancers (Basel)
. 2017 Dec;
9(12).
PMID: 29236051
A mini-ridge filter is often used to widen the Bragg peak in the longitudinal direction at low energies but not high energies. To facilitate the clinical use of a mini-ridge...
9.
Titt U, Suzuki K, Li Y, Sahoo N, Gillin M, Zhu X
Med Phys
. 2017 Oct;
44(12):6661-6671.
PMID: 28975637
Purpose: To systematically analyze and present the properties of a small-field, double-scattering proton beam line intended to be used for the treatment of ocular cancer, and to provide configuration data...
10.
Wang X, Poenisch F, Sahoo N, Zhu R, Lii M, Gillin M, et al.
J Appl Clin Med Phys
. 2016 Sep;
17(5):366-376.
PMID: 27685136
This is a real case study to minimize the neutron dose equivalent (H) to a fetus using spot scanning proton beams with favorable beam energies and angles. Minimum neutron dose...